Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression
Source abstract
Abstract
Nogo-B receptor (NgBR) plays fundamental roles in regulating angiogenesis, vascular development, and the epithelial-mesenchymal transition (EMT) of cancer cells. However, the therapeutic effect of NgBR blockade on tumor vasculature and malignancy is unknown, investigations on which requires an adequate delivery system for small interfering RNA against NgBR (NgBR siRNA). Here a surface charge switchable polymeric nanoparticle that was sensitive to the slightly acidic tumor microenvironment was developed for steady delivery of NgBR siRNA to tumor tissues. The nanoformulation was constructed by conjugating 2, 3-dimethylmaleic anhydride (DMMA) molecules to the surface amines of micelles formed by cationic co-polymer poly(lactic-co-glycolic acid)2-poly(ethylenimine) and subsequent absorption of NgBR siRNAs. The nanoparticles remained negatively charged in physiological condition and smartly converted to positive surface charge due to tumor-acidity-activated shedding of DMMA. The charge conversion facilitated cellular uptake of siRNAs and in turn efficiently depleted the expression of NgBR in tumor-bearing tissues. Silencing of NgBR suppressed endothelial cell migration and tubule formation, and reverted the EMT process of breast cancer cells. Delivery of the nanoformulation to mice bearing orthotopic breast carcinoma showed no effect on tumor growth, but led to remarkable decrease of distant metastasis by normalizing tumor vessels and suppressing the EMT of breast cancer cells. This study demonstrated that NgBR is a promising therapeutic target in abnormal tumor vasculature and aggressive cancer cells, and the tumor-responsive nanoparticle with the feature of charge transformation offers great potential for tumor-specific delivery of gene therapeutics.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Emerging biological principles of metastasis10.1016/j.cell.2016.11.037 ↗
2. The basics of epithelial-mesenchymal transition10.1172/JCI39104 ↗
3. EMT in cancer10.1038/nrc.2017.118 ↗
4. Targeting EMT in cancer: opportunities for pharmacological intervention10.1016/j.tips.2014.06.006 ↗
5. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases10.1038/nrd3455 ↗
6. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy10.1126/science.1104819 ↗
7. Effects of tumor microenvironments on targeted delivery of glycol chitosan nanoparticles10.1016/j.jconrel.2017.09.015 ↗
8. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment10.1073/pnas.95.8.4607 ↗
9. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia10.1016/j.ccell.2014.10.006 ↗
10. Tumor vessel normalization by chloroquine independent of autophagy
11. Intratumoral light restores pericyte contractile properties and vessel integrity10.1016/j.celrep.2015.12.004 ↗
12. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy10.1016/j.ccell.2016.10.006 ↗
13. Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment10.1016/j.ccell.2016.10.018 ↗
14. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors10.1038/ni.3836 ↗
15. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer
16. Comprehensive proteome quantification reveals NgBR as a new regulator for epithelial-mesenchymal transition of breast tumor cells10.1016/j.jprot.2014.08.007 ↗
17. Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway
18. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells
19. Nogo-B receptor is essential for angiogenesis in zebrafish via Akt pathway10.1182/blood-2010-02-271577 ↗
20. Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice10.1016/j.ydbio.2015.12.023 ↗
21. NgBR is essential for endothelial cell glycosylation and vascular development10.15252/embr.201540789 ↗
22. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures10.1016/j.biomaterials.2016.10.053 ↗
23. Delivery materials for siRNA therapeutics10.1038/nmat3765 ↗
24. Cell-penetrating peptides: design, synthesis, and applications10.1021/nn4057269 ↗
25. Factors affecting the clearance and biodistribution of polymeric nanoparticles10.1021/mp800051m ↗
26. Dysregulated pH: a perfect storm for cancer progression10.1038/nrc3110 ↗
27. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery10.1002/anie.200907210 ↗
28. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery10.1021/nn204240b ↗
29. Facile generation of tumor-pH-labile linkage-bridged block copolymers for chemotherapeutic delivery10.1002/anie.201509507 ↗
30. Self-assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging10.1016/j.jconrel.2013.12.037 ↗
31. Improvement of stability and efficacy of C16Y therapeutic peptide via molecular self-assembly into tumor-responsive nanoformulation10.1158/1535-7163.MCT-15-0484 ↗
32. Tumor microenvironment-specific nanoparticles activatable by stepwise transformation10.1016/j.jconrel.2016.05.009 ↗
33. Recent developments in nucleic acid delivery with polyethylenimines10.1016/B978-0-12-800148-6.00009-2 ↗
34. Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours10.1038/s41551-017-0115-8 ↗
35. PLGA-based nanoparticles: an overview of biomedical applications10.1016/j.jconrel.2012.01.043 ↗
36. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery10.1021/ja710344v ↗
37. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells10.1158/0008-5472.CAN-05-2292 ↗
38. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies10.1038/onc.2009.399 ↗
39. Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa10.1038/nrclinonc.2018.9 ↗